BioStem Technologies, Inc. (BSEM) Stock

Healthcare · Biotechnology · Member of Other US Stocks

BioStem Technologies, Inc. (BSEM) closed at USD 2.11 on 2026-10-14, a change of -53.1 % over the past year, with a market capitalization of USD 38.09M.

BioStem Technologies, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

BioStem Technologies, Inc. key figures

Previous close

USD 2.11 (2026-10-14)

1-year change

-53.1 %

Market cap

USD 38.09M

Enterprise value

USD 30.67M

P/E ratio (trailing)

2.46

P/E ratio (forward)

7.03

EPS (trailing)

0.83

EPS (forward)

0.29

PEG ratio

n/a

Price to book

1.32

Revenue growth

-27.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.54

Employees

73

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About BioStem Technologies, Inc.

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for BioStem Technologies, Inc. and compare it with other stocks.